Yiğit Ozgür, Uzun Hasan, Han Turgay, Cakir Burak Omür
Department of Otolaryngology, Sişli Etfal Training Hospital, Istanbul, Turkey.
Kulak Burun Bogaz Ihtis Derg. 2005;14(3-4):79-82.
We evaluated operative success rates of endoscopic dacryocystorhinostomy with or without bicanalicular silicone tube implantation.
Twenty-six eyes of 24 patients with simple epiphora (23 eyes) or chronic dacryocystitis (3 eyes) were treated by endoscopic dacryocystorhinostomy with (18 eyes) or without (8 eyes) bicanalicular silicone tube implantation. In the implantation group, one patient underwent endoscopic sinus surgery and two patients underwent submucosal resection. The silicone tubes were removed after a mean of 4.48 months (range 7 days to 6 months). The mean follow-up period was 12.4 months.
During the follow-up period, no significant differences were found between the two treatment groups with respect to the occurrence of epiphora. It disappeared in 17 eyes (94.5%) and in six eyes (75%) with or without silicone tube implantation, respectively. Operative success rates were significantly different between patients with simple epiphora (95.7%) and chronic dacryocystitis (33.3%). The only complication was a punctual damage seen in one patient.
The lack of a significantly high influence on the success rate, increased operative cost, and the risk for complications due to silicone tube insertions may be considered disadvantages of bicanalicular silicone tube implantation.
我们评估了内镜下泪囊鼻腔造口术联合或不联合双泪小管硅胶管植入术的手术成功率。
24例患者的26只眼，其中单纯溢泪（23只眼）或慢性泪囊炎（3只眼），接受了内镜下泪囊鼻腔造口术，其中18只眼联合双泪小管硅胶管植入，8只眼未植入。在植入组中，1例患者接受了鼻窦内镜手术，2例患者接受了黏膜下切除术。硅胶管平均在4.48个月（范围7天至6个月）后取出。平均随访期为12.4个月。
在随访期间，两组治疗组在溢泪发生率方面未发现显著差异。分别有17只眼（94.5%）和6只眼（75%）的溢泪症状消失，无论是否植入硅胶管。单纯溢泪患者（95.7%）和慢性泪囊炎患者（33.3%）的手术成功率有显著差异。唯一的并发症是1例患者出现泪点损伤。
对成功率缺乏显著的高影响、手术成本增加以及硅胶管插入导致并发症的风险，可能被认为是双泪小管硅胶管植入术的缺点。
